pubmed-article:18794258 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18794258 | lifeskim:mentions | umls-concept:C2349001 | lld:lifeskim |
pubmed-article:18794258 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
pubmed-article:18794258 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:18794258 | lifeskim:mentions | umls-concept:C0681850 | lld:lifeskim |
pubmed-article:18794258 | lifeskim:mentions | umls-concept:C1706203 | lld:lifeskim |
pubmed-article:18794258 | lifeskim:mentions | umls-concept:C2697811 | lld:lifeskim |
pubmed-article:18794258 | lifeskim:mentions | umls-concept:C0014822 | lld:lifeskim |
pubmed-article:18794258 | lifeskim:mentions | umls-concept:C0021308 | lld:lifeskim |
pubmed-article:18794258 | lifeskim:mentions | umls-concept:C0035126 | lld:lifeskim |
pubmed-article:18794258 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:18794258 | lifeskim:mentions | umls-concept:C0456389 | lld:lifeskim |
pubmed-article:18794258 | lifeskim:mentions | umls-concept:C1550501 | lld:lifeskim |
pubmed-article:18794258 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:18794258 | pubmed:dateCreated | 2008-10-3 | lld:pubmed |
pubmed-article:18794258 | pubmed:abstractText | Administration of erythropoietin (EPO) during or immediately after myocardial ischemia can reduce subsequent myocardial apoptosis, a key phenomenon in myocardial ischemia-reperfusion injury. In this study, we assessed the effect of EPO on (99m)Tc-annexin V myocardial uptake and whether the accumulation of (99m)Tc-annexin V can predict cardiac remodeling and functional deterioration. | lld:pubmed |
pubmed-article:18794258 | pubmed:language | eng | lld:pubmed |
pubmed-article:18794258 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18794258 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18794258 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18794258 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18794258 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18794258 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18794258 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18794258 | pubmed:month | Oct | lld:pubmed |
pubmed-article:18794258 | pubmed:issn | 0161-5505 | lld:pubmed |
pubmed-article:18794258 | pubmed:author | pubmed-author:AzumaAkihiroA | lld:pubmed |
pubmed-article:18794258 | pubmed:author | pubmed-author:UedaMasashiM | lld:pubmed |
pubmed-article:18794258 | pubmed:author | pubmed-author:MatsubaraHiro... | lld:pubmed |
pubmed-article:18794258 | pubmed:author | pubmed-author:OgawaKazumaK | lld:pubmed |
pubmed-article:18794258 | pubmed:author | pubmed-author:SajiHideoH | lld:pubmed |
pubmed-article:18794258 | pubmed:author | pubmed-author:DoueTomokiT | lld:pubmed |
pubmed-article:18794258 | pubmed:author | pubmed-author:OhtsukiKatsui... | lld:pubmed |
pubmed-article:18794258 | pubmed:author | pubmed-author:StraussHarry... | lld:pubmed |
pubmed-article:18794258 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18794258 | pubmed:volume | 49 | lld:pubmed |
pubmed-article:18794258 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18794258 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18794258 | pubmed:pagination | 1694-700 | lld:pubmed |
pubmed-article:18794258 | pubmed:meshHeading | pubmed-meshheading:18794258... | lld:pubmed |
pubmed-article:18794258 | pubmed:meshHeading | pubmed-meshheading:18794258... | lld:pubmed |
pubmed-article:18794258 | pubmed:meshHeading | pubmed-meshheading:18794258... | lld:pubmed |
pubmed-article:18794258 | pubmed:meshHeading | pubmed-meshheading:18794258... | lld:pubmed |
pubmed-article:18794258 | pubmed:meshHeading | pubmed-meshheading:18794258... | lld:pubmed |
pubmed-article:18794258 | pubmed:meshHeading | pubmed-meshheading:18794258... | lld:pubmed |
pubmed-article:18794258 | pubmed:meshHeading | pubmed-meshheading:18794258... | lld:pubmed |
pubmed-article:18794258 | pubmed:meshHeading | pubmed-meshheading:18794258... | lld:pubmed |
pubmed-article:18794258 | pubmed:meshHeading | pubmed-meshheading:18794258... | lld:pubmed |
pubmed-article:18794258 | pubmed:meshHeading | pubmed-meshheading:18794258... | lld:pubmed |
pubmed-article:18794258 | pubmed:meshHeading | pubmed-meshheading:18794258... | lld:pubmed |
pubmed-article:18794258 | pubmed:meshHeading | pubmed-meshheading:18794258... | lld:pubmed |
pubmed-article:18794258 | pubmed:meshHeading | pubmed-meshheading:18794258... | lld:pubmed |
pubmed-article:18794258 | pubmed:meshHeading | pubmed-meshheading:18794258... | lld:pubmed |
pubmed-article:18794258 | pubmed:meshHeading | pubmed-meshheading:18794258... | lld:pubmed |
pubmed-article:18794258 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18794258 | pubmed:articleTitle | Cardioprotective effects of erythropoietin in rats subjected to ischemia-reperfusion injury: assessment of infarct size with 99mTc-annexin V. | lld:pubmed |
pubmed-article:18794258 | pubmed:affiliation | Department of Cardiology and Nephrology, Kyoto Prefectural University of Medicine, Kyoto, Japan. doue@meiji-u.ac.jp | lld:pubmed |
pubmed-article:18794258 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18794258 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |